Whitcup Scott M
SEC-identified person · CIK 1298941 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Avalanche Biotechnologies, Inc. [AAVL] | Director | filed 2020 - 2025 |
| Vyne Therapeutics Inc. VYNE | Director | filed 2018 - 2019 |
| Nightstar Therapeutics plc NITE | Director | filed 2019 - 2019 |
| Allergan INC AGN | Executive Vice President, R&D | filed 2006 - 2015 |
| Questcor Pharmaceuticals INC QSC | Director | filed 2012 - 2014 |
| Avanir Pharmaceuticals, INC. AVNR | Director | filed 2006 - 2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.